Meeder Asset Management Inc

Source: SEC Form 13F · as of Mar 2026

Meeder Asset Management Inc holds 78 biotech & pharma companies tracked by BioSniper, totaling $169.0M in value as of Mar 2026 (SEC Form 13F).

Companies held

78

Total value held

$169.0M

CompanySharesValue
JNJJOHNSON & JOHNSON144,080$35.2M
LLYELI LILLY & Co29,919$27.5M
AMGNAMGEN INC65,302$23.0M
GILDGILEAD SCIENCES, INC.147,283$20.5M
ABBVAbbVie Inc.79,562$17.3M
MRKMerck & Co., Inc.84,741$10.2M
MCKMcKesson Corporation8,135$7.0M
ELVElevance Health Inc.19,555$5.7M
ZTSZoetis Inc.45,286$5.4M
UNHUnitedHealth Group Incorporated Common Stock (DE)18,340$5.0M
REGNREGENERON PHARMACEUTICALS, INC.6,094$4.7M
VRTXVERTEX PHARMACEUTICALS INC / MA3,424$1.5M
BMYBRISTOL MYERS SQUIBB CO16,853$1.0M
GMOptec International, Inc.13,106$976K
UTHRUNITED THERAPEUTICS Corp1,503$891K
CAHCardinal Health Inc.2,628$555K
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.1,917$331K
CPRXCATALYST PHARMACEUTICALS, INC.10,392$257K
BIIBBIOGEN INC.1,071$196K
PMPhilip Morris International Inc971$161K
PAHCPHIBRO ANIMAL HEALTH CORP1,969$109K
BMRNBIOMARIN PHARMACEUTICAL INC1,838$104K
NUSNu Skin Enterprises Inc.13,821$101K
WSTWest Pharmaceutical Services Inc.386$97K
ADMAADMA BIOLOGICS, INC.9,759$88K
ABTABBOTT LABORATORIES840$86K
IDXXIDEXX LABORATORIES INC /DE151$85K
PFEPFIZER INC2,789$78K
VCELVericel Corp1,900$61K
NRCNational Research Corporation Common Stock (Delaware)2,884$49K
PCRXPacira BioSciences, Inc.2,036$46K
CORCencora Inc.127$40K
DGXQuest Diagnostics Incorporated182$36K
MNPRMonopar Therapeutics637$35K
ENTAENANTA PHARMACEUTICALS INC2,025$26K
VTRSViatris Inc1,643$22K
ACADACADIA PHARMACEUTICALS INC984$22K
ALNYALNYLAM PHARMACEUTICALS, INC.66$22K
GEHCGE HealthCare Technologies Inc.306$22K
PRGOPERRIGO Co plc1,976$21K
INSMINSMED Inc125$20K
IQVIQVIA Holdings Inc.108$18K
KODKodiak Sciences Inc.481$18K
EBSEmergent BioSolutions Inc.2,057$17K
ZBHZimmer Biomet Holdings Inc.160$14K
ANABANAPTYSBIO, INC240$13K
IONSIONIS PHARMACEUTICALS INC152$11K
ELANElanco Animal Health Inc474$11K
MRNAModerna, Inc.223$11K
INCYIncyte Corp.118$11K
BIOABioAge Labs, Inc.631$11K
CRVSCorvus Pharmaceuticals, Inc.754$11K
NUVLNuvalent, Inc.105$11K
LFCRLIFECORE BIOMEDICAL, INC. DE2,873$11K
RVMDREVOLUTION MEDICINES, INC.106$10K
NBIXNEUROCRINE BIOSCIENCES INC78$10K
BBIOBridgeBio Pharma, Inc.129$10K
CSTLCastle Biosciences Inc.387$10K
CYTKCYTOKINETICS INC142$9K
AMLXAmylyx Pharmaceuticals, Inc.661$9K
MDGLMADRIGAL PHARMACEUTICALS, INC.17$9K
IDYAIDEAYA Biosciences, Inc.251$8K
ROIVRoivant Sciences Ltd.287$8K
JAZZJazz Pharmaceuticals plc42$8K
PCVXVaxcyte, Inc.133$8K
GHGuardant Health Inc.81$7K
MGXMetagenomi Therapeutics, Inc.5,496$7K
BAXBaxter International Inc.421$7K
DFTXDefinium Therapeutics Inc.353$7K
CRNXCrinetics Pharmaceuticals, Inc.177$6K
ARWRARROWHEAD PHARMACEUTICALS, INC.102$6K
RXRXRECURSION PHARMACEUTICALS, INC.1,970$6K
CRSPCRISPR Therapeutics AG122$6K
COGTCogent Biosciences, Inc.140$5K
PRAXPraxis Precision Medicines, Inc.16$5K
VKTXViking Therapeutics, Inc.155$5K
MOHMolina Healthcare Inc36$5K
TERNTerns Pharmaceuticals, Inc.62$3K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Meeder Asset Management Inc — Biotech 13F Holdings & Portfolio | BioSniper